STAT

Opinion: You can’t tell a book by its cover — or a disease by Drake’s race

Diagnoses based on race are wrong on many levels.
A diagram of rapper Drake's parents is no way to study disease diagnosis.

In my first year of medical school, I walked into a study room to find a Venn diagram on the whiteboard. Underneath the title “Diseases Drake is at Risk for Developing” floated two intersecting circles, subtitled “Black Daddy” and “White Jewish Mommy.”

Drake is the multimillion-dollar rapper with the most charted songs for a solo artist in the history of the Billboard Hot 100. But on this whiteboard, he’s just a man with a Black Daddy and a White Jewish Mommy. What struck me was how crudely a hypothetical patient had been reduced to his race.

The diagram hadn’t been drawn — the brutal, nine-hour assessment that medical students must take before graduation. One of the time-saving tricks we learn is to associate race with disease. A black child under 10 years old? Sickle cell disease. An Asian patient with weak pulses? Takayasu’s vasculitis. Urban man of color? Think drug use or violent trauma. A Mexican patient with gastrointestinal distress? Parasites from contaminated water. A white newborn that hasn’t passed meconium? Bet on cystic fibrosis.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks